Expected impact of COVID-19 on personal income in G7 countries March 2020

Published by
Einar H. Dyvik,
Aug 6, 2024
According to a survey conducted towards the end of March 2020, 29 percent of respondents residing in G7 countries have already had their personal income impacted by the coronavirus pandemic (COVID-19).

Opinion of adults in G7 countries of the expected impact of the COVID-19 pandemic on their personal income as of March 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2020

Region

Worldwide

Survey time period

March 19 to 21, 2020

Number of respondents

7,005 respondents

Age group

16 years and older

Special properties

G7 countries

Method of interview

Online survey

Supplementary notes

Original question: "Thinking about your personal income, which one of these statements comes closest to your current situation?"
Total participants from each country:
Canada - 1,000
France - 1,000
Germany - 1,004
Italy - 1,000
Japan - 1,000
Great Britain - 1,001
The United States - 1,000
The source does not indicate why responses do not total 100 percent.

Citation formats
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus: impact on the retail industry worldwideCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.Coronavirus (COVID-19): impact on the retail landscape in the U.S.
Access all statistics starting from $1,788 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$149 USD $199 USD
per month, billed annually 1
Buy now
25% off until Sep 30th
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu